- Scrip Originals
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Avicanna Inc.
AbbVie pays $130m up front with up to $870m in earnout potential for UCB spinout focused on SV2A modulators. BioNTech gets rights to preclinical TCR candidates for solid tumors from Medigene.